A recent study in GC showed that the reader IGF3BP1 recognized METTL3-mediated m6A modification on apoptotic protease-activating factor 1-binding lncRNA to maintain its stability, which inhibited GC cell apoptosis and led to multidrug resistance [147]. The gene discussed is METTL3; the disease is gastric cancer.